disitamab vedotin,Pembrolizumab
rongchang pharma,,seagen,merck
[' vedo', 'rc48', 'urothelial', 'disitamab']
phase 2 clinical study evaluating the efficacy and safety of disitamab vedotin in pts with her2-expressing #urothelialcarcinoma (rc48g001, trial in progress). presentation by . #esmo22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology